Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Fibrogenesis & Tissue Repair
Published in: Fibrogenesis & Tissue Repair 1/2009

Open Access 01-12-2009 | Review

Possible mechanisms of kidney repair

Authors: Paola Romagnani, Raghu Kalluri

Published in: Fibrogenesis & Tissue Repair | Issue 1/2009

Login to get access

Abstract

In most adult epithelia the process of replacing damaged or dead cells is maintained through the presence of stem/progenitor cells, which allow epithelial tissues to be repaired following injury. Existing evidence strongly supports the presence of stem cells in the adult kidney. Indeed, recent findings provide evidence in favour of a role for intrinsic renal cells and against a physiological role for bone marrow-derived stem cells in the regeneration of renal epithelial cells. In addition, recent studies have identified a subset of CD24+CD133+ renal progenitors within the Bowman's capsule of adult human kidney, which provides regenerative potential for injured renal epithelial cells. Intriguingly, CD24+CD133+ renal progenitors also represent common progenitors of tubular cells and podocytes during renal development. Chronic injury causes dysfunction of the tubular epithelial cells, which triggers the release of fibrogenic cytokines and recruitment of inflammatory cells to injured kidneys. The rapid interposition of scar tissue probably confers a survival advantage by preventing infectious microorganisms from invading the wound, but prevents subsequent tissue regeneration. However, the existence of renal epithelial progenitors in the kidney suggests a possible explanation for the regression of renal lesions which has been observed in experimental animals and even in humans. Thus, manipulation of the wound repair process in order to shift it towards regeneration will probably require the ability to slow the rapid fibrotic response so that renal progenitor cells can allow tissue regeneration rather than scar formation.
Appendix
Available only for authorised users
Literature
1.
2.
Dressler GR: The cellular basis of kidney development. Annu Rev Cell Dev Biol. 2006, 22: 509-529. 10.1146/annurev.cellbio.22.010305.104340.CrossRefPubMed
3.
Little MH: Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol. 2006, 17: 2390-2401. 10.1681/ASN.2006030218.CrossRefPubMed
4.
Remuzzi G, Benigni A, Remuzzi A: Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest. 2006, 116: 288-296. 10.1172/JCI27699.PubMedCentralCrossRefPubMed
5.
Imai E, Iwatani H: The continuing story of renal repair with stem cells. J Am Soc Nephrol. 2007, 18: 2423-2424. 10.1681/ASN.2007070769.CrossRefPubMed
6.
Lin F, Moran A, Igarashi P: Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in post ischemic kidney. J Clin Invest. 2005, 115: 1756-1764. 10.1172/JCI23015.PubMedCentralCrossRefPubMed
7.
Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, Bonventre JV: Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest. 2005, 115: 1743-1755. 10.1172/JCI22593.PubMedCentralCrossRefPubMed
8.
Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, Camussi G: Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 2005, 166: 545-555.PubMedCentralCrossRefPubMed
9.
Dekel B, Zangi L, Shezen E, Reich-Zeliger S, Eventov-Friedman S, Katchman H, Jacob-Hirsch J, Amariglio N, Rechavi G, Margalit R, Reisner Y: Isolation and characterization of nontubular sca-1+lin_multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol. 2006, 17: 3300-3314. 10.1681/ASN.2005020195.CrossRefPubMed
10.
Gupta S, Verfaillie C, Chmielewski D, Kren S, Eidman K, Connaire J, Heremans Y, Lund T, Blackstad M, Jiang Y, Luttun A, Rosenberg ME: Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol. 2006, 17: 3028-3040. 10.1681/ASN.2006030275.CrossRefPubMed
11.
Kitamura S, Yamasaki Y, Kinomura M, Sugaya T, Sugiyama H, Maeshima Y, Makino H: Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J. 2005, 19: 1789-1797. 10.1096/fj.05-3942com.CrossRefPubMed
12.
Maeshima A, Yamashita S, Nojima Y: Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol. 2003, 14: 3138-3146. 10.1097/01.ASN.0000098685.43700.28.CrossRefPubMed
13.
Maeshima A, Sakurai H, Nigam SK: Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol. 2006, 17: 188-198. 10.1681/ASN.2005040370.CrossRefPubMed
14.
15.
Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M, Squecco R, Carini M, Gesualdo L, Francini F, Maggi E, Annunziato F, Lasagni L, Serio M, Romagnani S, Romagnani P: Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol. 2006, 17: 2443-2456. 10.1681/ASN.2006010089.CrossRefPubMed
16.
Kiel MJ, He S, Ashkenazi R, Gentry SN, Teta M, Kushner JA, Jackson TL, Morrison SJ: Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature. 2007, 449: 238-242. 10.1038/nature06115.PubMedCentralCrossRefPubMed
17.
Kim D, Dressler GR: Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol. 2005, 16: 3527-3534. 10.1681/ASN.2005050544.CrossRefPubMed
18.
Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, McMahon AP, Bonventre JV: Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008, 2: 284-291. 10.1016/j.stem.2008.01.014.CrossRefPubMed
19.
Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE: Generation of a functional mammary gland from a single stem cell. Nature. 2006, 439: 84-88. 10.1038/nature04372.CrossRefPubMed
20.
Kubota H, Avarbock MR, Brinster RL: Spermatogonial stem cells share some, but not all, phenotypic and functional characteristics with other stem cells. Proc Natl Acad Sci USA. 2003, 100: 6487-6492. 10.1073/pnas.0631767100.PubMedCentralCrossRefPubMed
21.
Coskun V, Wu H, Blanchi B, Tsao S, Kim K, Zhao J, Biancotti JC, Hutnick L, Krueger RC, Fan G, de Vellis J, Sun YE: CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci USA. 2008, 105: 1026-1031. 10.1073/pnas.0710000105.PubMedCentralCrossRefPubMed
22.
Shmelkov SV, St Clair R, Lyden D, Rafii S: AC133/CD133/Prominin-1. Int J Biochem Cell Biol. 2005, 37: 715-719. 10.1016/j.biocel.2004.08.010.CrossRefPubMed
23.
24.
Morrison SJ, Kimble J: Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006, 441: 1068-1074. 10.1038/nature04956.CrossRefPubMed
25.
Self M, Lagutin OV, Bowling B, Hendrix J, Cai Y, Dressler GR, Oliver G: Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J. 2006, 25: 5214-5228. 10.1038/sj.emboj.7601381.PubMedCentralCrossRefPubMed
26.
Oliver JA, Barasch J, Yang J, Herzlinger D, Al-Awqati Q: Metanephric mesenchyme contains embryonic renal stem cells. Am J Physiol Renal Physiol. 2002, 283: F799-F809.CrossRefPubMed
27.
Herzlinger D, Koseki C, Mikawa T, Al-Awqati Q: Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction. Development. 1992, 114: 565-572.PubMed
28.
Lazzeri E, Crescioli C, Ronconi E, Mazzinghi B, Sagrinati C, Netti GS, Angelotti ML, Parente E, Ballerini L, Cosmi L, Maggi L, Gesualdo L, Rotondi M, Annunziato F, Maggi E, Lasagni L, Serio M, Romagnani S, Vannelli GB, Romagnani P: Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol. 2007, 18: 3128-3138. 10.1681/ASN.2007020210.CrossRefPubMed
29.
Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ: BmI-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 2003, 425: 962-967. 10.1038/nature02060.PubMedCentralCrossRefPubMed
30.
Kozakowski N, Soleiman A, Pammer J: BMI-1 expression is inversely correlated with the grading of renal clear cell carcinoma. Pathol Oncol Res. 2008, 14: 9-13. 10.1007/s12253-008-9006-3.CrossRefPubMed
31.
Dekel B, Burakova T, Arditti FD, Reich-Zeliger S, Milstein O, Aviel-Ronen S, Rechavi G, Friedman N, Kaminski N, Passwell JH, Reisner Y: Human and porcine early kidney precursors as a new source for transplantation. Nat Med. 2003, 9: 53-60. 10.1038/nm812.CrossRefPubMed
32.
Scadden DT: The stem-cell niche as an entity of action. Nature. 2006, 441: 1075-1079. 10.1038/nature04957.CrossRefPubMed
33.
Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001, 105: 369-377. 10.1016/S0092-8674(01)00328-2.CrossRefPubMed
34.
Kobayashi A, Valerius MT, Mugford JW, Carroll TJ, Self M, Oliver G, McMahon AP: Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008, 3: 169-81. 10.1016/j.stem.2008.05.020.PubMedCentralCrossRefPubMed
35.
Phinney DG, Prockop DJ: Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair – current views. Stem Cells. 2007, 25: 2896-2902. 10.1634/stemcells.2007-0637.CrossRefPubMed
36.
Spyridonidis A, Zeiser R, Follo M, Metaxas Y, Finke J: Stem cell plasticity: the debate begins to clarify. Stem Cell Rev. 2005, 1: 37-43. 10.1385/SCR:1:1:037.CrossRefPubMed
37.
Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000, 6: 1229-1234. 10.1038/81326.CrossRefPubMed
38.
Herzog EL, Chai L, Krause DS: Plasticity of marrow-derived stem cells. Blood. 2003, 102: 3483-3493. 10.1182/blood-2003-05-1664.CrossRefPubMed
39.
Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG: Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 2003, 112: 42-49.PubMedCentralCrossRefPubMed
40.
Poulsom R, Forbes SJ, Hodivala-Dilke K, Ryan E, Wyles S, Navaratnarasah S, Jeffery R, Hunt T, Alison M, Cook T, Pusey C, Wright NA: Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol. 2001, 195: 229-235. 10.1002/path.976.CrossRefPubMed
41.
Morigi M, Benigni A, Remuzzi G, Imberti B: The regenerative potential of stem cells in acute renal failure. Cell Transplant. 2006, 15: S111-S117. 10.3727/000000006783982449.CrossRefPubMed
42.
Ikarashi K, Li B, Suwa M, Kawamura K, Morioka T, Yao J, Khan F, Uchiyama M, Oite T: Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int. 2005, 67: 1925-1933. 10.1111/j.1523-1755.2005.00291.x.CrossRefPubMed
43.
Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, Igarashi P: Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol. 2003, 14: 1188-1199. 10.1097/01.ASN.0000061595.28546.A0.CrossRefPubMed
44.
Imasawa T, Utsunomiya Y, Kawamura T, Zhong Y, Nagasawa R, Okabe M, Maruyama N, Hosoya T, Ohno T: The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol. 2001, 12: 1401-1409.PubMed
45.
Kunter U, Rong S, Boor P, Eitner F, Müller-Newen G, Djuric Z, van Roeyen CR, Konieczny A, Ostendorf T, Villa L, Milovanceva-Popovska M, Kerjaschki D, Floege J: Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol. 2006, 17: 2202-2212. 10.1681/ASN.2005080815.CrossRefPubMed
46.
Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG: Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol. 2007, 18: 2486-2496. 10.1681/ASN.2007020140.CrossRefPubMed
47.
Sugimoto H, Mundel TM, Sund M, Xie L, Cosgrove D, Kalluri R: Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci USA. 2006, 103: 7321-7326. 10.1073/pnas.0601436103.PubMedCentralCrossRefPubMed
48.
Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G: Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004, 15: 1794-1804. 10.1097/01.ASN.0000128974.07460.34.CrossRefPubMed
49.
Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005, 289: F31-F42. 10.1152/ajprenal.00007.2005.CrossRefPubMed
50.
Lange C, Tögel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C: Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005, 68: 1613-1617. 10.1111/j.1523-1755.2005.00573.x.CrossRefPubMed
51.
Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007, 292: F1626-F1635. 10.1152/ajprenal.00339.2006.CrossRefPubMed
52.
Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, Stamenkovic I, Biancone L, Camussi G: Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007, 72: 430-441. 10.1038/sj.ki.5002334.CrossRefPubMed
53.
Li B, Morioka T, Uchiyama M, Oite T: Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int. 2006, 69 (2): 323-330. 10.1038/sj.ki.5000083.CrossRefPubMed
54.
Kunter U, Rong S, Boor P, Eitner F, Müller-Newen G, Djuric Z, van Roeyen CR, Konieczny A, Ostendorf T, Villa L, Milovanceva-Popovska M, Kerjaschki D, Floege J: Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol. 2007, 18: 1754-1764. 10.1681/ASN.2007010044.CrossRefPubMed
55.
Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, Abbate M, Zoja C, Remuzzi G: Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol. 2007, 18: 2921-2928. 10.1681/ASN.2006121318.CrossRefPubMed
56.
Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G: Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004, 14: 1035-1041.PubMed
57.
Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, Pusey CD, Cook HT: Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells. 2006, 24: 2448-2455. 10.1634/stemcells.2006-0201.CrossRefPubMed
58.
Ninichuk V, Gross O, Segerer S, Hoffmann R, Radomska E, Buchstaller A, Huss R, Akis N, Schlöndorff D, Anders HJ: Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int. 2006, 70: 121-129. 10.1038/sj.ki.5001521.CrossRefPubMed
59.
Guo JK, Schedl A, Krause DS: Bone marrow transplantation can attenuate the progression of mesangial sclerosis. Stem Cells. 2006, 24: 406-415. 10.1634/stemcells.2005-0139.CrossRefPubMed
60.
Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M: In vivo genetic selection of renal proximal tubules. Mol Ther. 2006, 13: 49-58. 10.1016/j.ymthe.2005.09.004.CrossRefPubMed
61.
Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH, Wong MH: Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA. 2006, 103: 6321-6325. 10.1073/pnas.0508593103.PubMedCentralCrossRefPubMed
62.
Masuya M, Drake CJ, Fleming PA, Reilly CM, Zeng H, Hill WD, Martin-Studdard A, Hess DC, Ogawa M: Hematopoietic origin of glomerular mesangial cells. Blood. 2003, 101: 2215-2218. 10.1182/blood-2002-04-1076.CrossRefPubMed
63.
Abe T, Fleming PA, Masuya M, Minamiguchi H, Ebihara Y, Drake CJ, Ogawaa M: Granulocyte/macrophage origin of glomerular mesangial cells. Int J Hematol. 2005, 82: 115-118. 10.1532/IJH97.05018.CrossRefPubMed
64.
Takeda S, Rogers SA, Hammerman MR: Differential origin for endothelial and mesangial cells after transplantation of pig fetal renal primordia into rats. Transpl Immunol. 2006, 15: 211-215. 10.1016/j.trim.2005.10.003.CrossRefPubMed
65.
Rookmaaker MB, Verhaar MC, Van Zonneveld AJ, Rabelink TJ: Progenitor cells in the kidney: Biology and therapeutic perspectives. Kidney Int. 2004, 66: 518-522. 10.1111/j.1523-1755.2004.761_10.x.CrossRefPubMed
66.
Rookmaaker MB, Tolboom H, Goldschmeding R, Zwaginga JJ, Rabelink TJ, Verhaar MC: Bone marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol. 2003, 163: 553-562.PubMedCentralCrossRefPubMed
67.
Williams GM, Alvarez CA: Host repopulation of the endothelium in allografts of kidneys and aorta. Surg Forum. 1969, 20: 293-294.PubMed
68.
Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH: Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 2001, 357: 33-37. 10.1016/S0140-6736(00)03569-8.CrossRefPubMed
69.
Rookmaaker MB, Tolboom H, Goldschmeding R, Zwaginga JJ, Rabelink TJ, Verhaar MC: Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy. Blood. 2002, 99: 1095-10.1182/blood.V99.3.1095.CrossRefPubMed
70.
Ito M, Liu Y, Yang Z, Nguyen J, Liang F, Morris RJ, Cotsarelis G: Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nature Med. 2005, 11: 1351-1354. 10.1038/nm1328.CrossRefPubMed
71.
Levy V, Lindon C, Harfe BD, Morgan BA: Distinct stem cell populations regenerate the follicle and interfollicular epidermis. Dev Cell. 2005, 9: 855-861. 10.1016/j.devcel.2005.11.003.CrossRefPubMed
72.
Finckh ES, Joske RA: The occurrence of columnar epithelium in Bowman's capsule. J Path Bact. 1954, 68: 646-648. 10.1002/path.1700680243.CrossRefPubMed
73.
Nachman RL: Metaplasia of parietal capsular epithelium of renal glomerulus. Arch Path. 1962, 73: 48-52.PubMed
74.
Kanel GC, Peters RL: Glomerular tubular reflux – a morphologic renal lesion associated with the hepatorenal syndrome. Hepatology. 1984, 4: 242-246. 10.1002/hep.1840040212.CrossRefPubMed
75.
Valdes AJ, Zhang JM: Intraglomerular tubular epithelial cells. A marker of glomerular hematuria. Arch Pathol Lab Med. 1987, 111: 189-191.PubMed
76.
Andrews PM: The presence of proximal tubule-like cells in the kidney parietal epithelium in response to unilateral nephrectomy. Anat Rec. 1981, 200: 61-65. 10.1002/ar.1092000106.CrossRefPubMed
77.
Castelletto L, Goya RG: Sex-related incidence of tubular metaplasia in Bowman's capsule of aging rats. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990, 59: 79-82. 10.1007/BF02899390.CrossRefPubMed
78.
Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, Angelotti ML, Parente E, Mancina R, Netti GS, Becherucci F, Gacci M, Carini M, Gesualdo L, Rotondi M, Maggi E, Lasagni L, Serio M, Romagnani S, Romagnani P: Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med. 2008, 205: 479-490. 10.1084/jem.20071903.PubMedCentralCrossRefPubMed
79.
Sagrinati C, Ronconi E, Lazzeri E, Lasagni L, Romagnani P: Stem-cell approaches for kidney repair: choosing the right cells. Trends Mol Med. 2008, 14: 277-285. 10.1016/j.molmed.2008.05.005.CrossRefPubMed
80.
Wiggins RC: The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007, 71: 1205-1214. 10.1038/sj.ki.5002222.CrossRefPubMed
81.
D'Agati VD: Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). Kidney Int. 2008, 73: 399-406. 10.1038/sj.ki.5002655.CrossRefPubMed
82.
Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Hozman LB, Wiggins RC: Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 2005, 16: 2941-2952. 10.1681/ASN.2005010055.CrossRefPubMed
83.
Bariety J, Mandet C, Hill GS, Bruneval P: Parietal podocytes in normal human glomeruli. J Am Soc Nephrol. 2006, 17: 2770-2780. 10.1681/ASN.2006040325.CrossRefPubMed
84.
Ronconi E, Sagrinati C, Angelotti ML, Lazzeri E, Mazzinghi B, Ballerini L, Parente E, Becherucci F, Gacci M, Carini M, Maggi E, Serio M, Vannelli GB, Lasagni L, Romagnani S, Romagnani P: Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol. 2009, 20: 322-32. 10.1681/ASN.2008070709.PubMedCentralCrossRefPubMed
85.
Gurtner GC, Werner S, Barrandon Y, Longaker MT: Wound repair and regeneration. Nature. 2008, 453: 314-321. 10.1038/nature07039.CrossRefPubMed
86.
Singer AJ, Clark RA: Cutaneous wound healing. N Engl J Med. 1999, 341: 738-746. 10.1056/NEJM199909023411006.CrossRefPubMed
87.
Aarabi S, Longaker MT, Gurtner GC: Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med. 2007, 4: e234-10.1371/journal.pmed.0040234.PubMedCentralCrossRefPubMed
88.
Neilson EG: Mechanisms of disease: Fibroblasts – a new look at an old problem. Nat Clin Pract Nephrol. 2006, 2: 101-108. 10.1038/ncpneph0093.CrossRefPubMed
89.
90.
Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J: TGF-beta signaling in vascular fibrosis. Cardiovasc Res. 2007, 74: 196-206. 10.1016/j.cardiores.2007.02.008.CrossRefPubMed
91.
Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J: Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant. 2006, 21: 16-20. 10.1093/ndt/gfi265.CrossRefPubMed
92.
Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N: Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest. 1999, 104: 13-19. 10.1172/JCI5628.PubMedCentralCrossRefPubMed
93.
Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G: The myofibroblast: one function, multiple origins. Am J Pathol. 2007, 170: 1807-1816. 10.2353/ajpath.2007.070112.PubMedCentralCrossRefPubMed
94.
Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, Brenner DA: Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol. 2006, 45: 429-438. 10.1016/j.jhep.2006.04.014.CrossRefPubMed
95.
Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R: Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol. 2008, 19: 2282-2287. 10.1681/ASN.2008050513.PubMedCentralCrossRefPubMed
96.
Sironi L, Nobili E, Gianella A, Gelosa P, Tremoli E: Anti-inflammatory properties of drugs acting on the renin-angiotensin system. Drugs Today (Barc). 2005, 41: 609-622. 10.1358/dot.2005.41.9.899613.CrossRef
97.
98.
Lin SL, Kisseleva T, Brenner DA, Duffield JS: Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol. 2008, 173: 1617-1627. 10.2353/ajpath.2008.080433.PubMedCentralCrossRefPubMed
99.
Romagnani P, Lasagni L, Mazzinghi B, Lazzeri E, Romagnani S: Pharmacological modulation of stem cell function. Curr Med Chem. 2007, 14: 1129-1139. 10.2174/092986707780362880.CrossRefPubMed
Metadata
Title
Possible mechanisms of kidney repair
Authors
Paola Romagnani
Raghu Kalluri
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Fibrogenesis & Tissue Repair / Issue 1/2009
Electronic ISSN: 1755-1536
DOI
https://doi.org/10.1186/1755-1536-2-3

Other articles of this Issue 1/2009

Fibrogenesis & Tissue Repair 1/2009 Go to the issue

Short review

Hepatic wound repair

Review

Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis _ state of the art

Research

Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods

Research

Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty

Research

Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells

Review

Role of host genetics in fibrosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits